Join to View Full Profile
900 Centennial BlvdBldg 1Voorhees, NJ 08043
Phone+1 856-632-2667
Fax+1 856-735-6478
Dr. Jaslow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board certified medical oncologist specializing in breast cancer/high risk/clinical genetics. I completed my medical training including both medical school and my internship and residency at The Mount Sinai Hospital, NY/NY and my Hematology-Oncology Fellowship at The New York Hospital-Weill Cornell Medical Center, NY/NY. I treat all types of breast cancer including early stage, metastatic, male breast Ca, inflammatory. I also have interest and experience in clinical trial management.
Education & Training
New York-Presbyterian HospitalFellowship, 1999 - 2002
Icahn School of Medicine at Mount SinaiResidency, 1996 - 1999- Icahn School of Medicine at Mount SinaiClass of 1996
Duke UniversityBS, Psychology/Biologic Basis of Behavior, Cum Laude, 1988 - 1992
Certifications & Licensure
PA State Medical License 2002 - 2026
NJ State Medical License 2017 - 2025
DE State Medical License 2017 - 2023
NY State Medical License 1997 - 2002
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 36 citationsAssociation of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA.Zhong Ye, Chun Wang, Shaogui Wan, Zhaomei Mu, Zhenchao Zhang
European Journal of Cancer. 2019-01-01 - 19 citationsImpact of Oncotype DX on Treatment Decisions in ER‐Positive, Node‐Negative Breast Cancer with Histologic CorrelationJulianne R. Biroschak, Gordon F. Schwartz, Juan P. Palazzo, Adam D. Toll, Kristin Brill
The Breast Journal. 2013-05-01 - 107 citationsp53 Overexpression as a Marker of Poor Prognosis in Mantle Cell Lymphomas With t(11; 14)(q13;q32)Diane C. Louie, Kenneth Offit, R. Jaslow, Nasser Z. Parsa, Vundavalli V. Murty
Blood. 1995-10-15
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
